2025
2024–2025
2024
- Young Adult Survivorship
- Living with Bladder Cancer
- Living with Metastatic Prostate Cancer
- Living with Metastatic Triple Negative Breast Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Life with Chronic Lymphocytic Leukemia (CLL)
- Living with Advanced Skin Cancer and Melanoma
- Living with Multiple Myeloma
- The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
- Living with Myeloproliferative Neoplasms (MPNs)
- Living with Bladder Cancer
2023–2024
- Young Adult Cancer Survivorship: Tips to Cope
- Living with Non-Small Cell Lung Cancer
- Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
2023
- Living with Metastatic Prostate Cancer
- Living with Metastatic Triple Negative Breast Cancer
- Highlights from the 2023 American Society of Clinical Oncology Meeting
- Living with Small Cell Lung Cancer
- How Health Care Disparities May Influence Your Cancer Treatment and Care
- Living with Advanced Skin Cancer and Melanoma
- Living with Metastatic Prostate Cancer
- New Trends in Immunotherapy
- Living with Non-Small Cell Lung Cancer
- Living with Multiple Myeloma
2022–2023
- Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
2022
- Living with Metastatic Triple Negative Breast Cancer
- Highlights from the 2022 ASCO Annual Meeting
- Life with Bladder Cancer
- Living with Non-Small Cell Lung Cancer
- Living with Small Cell Lung Cancer
- New Trends in Immunotherapy
- How Health Care Disparities May Influence Your Cancer Treatment and Care
- Living with Mantle Cell Lymphoma (MCL)
- Living with Advanced Skin Cancer and Melanoma
- Living with Chronic Lymphocytic Leukemia
2021–2022
2021
2020
2019
2014
2013
- The Eleventh Annual Cancer Survivorship Workshop: Living With, Through and Beyond Cancer
- Going the Distance: Thriving and Surviving with Chronic Myelogenous Leukemia (CML)